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Abstract PXMP1-L (synonyms: PMP69, P70R) is a perox-
isomal protein that belongs to the ABC-transporter superfamily.
Its closest homolog is the peroxisomal membrane protein 1
(PMP70). We have cloned the mouse PXMP1-L gene. It
encodes a 606 amino acid protein. In contrast to the human and
the rat, mouse PXMP1-L is predominantly expressed in the liver.
The mouse PXMP1-L gene consists of 19 exons and spans 21 kb
of genomic sequence. No obvious peroxisome proliferator
response element has been found in 1.1 kb of the putative
promoter region. No coordination of constitutive or fenofibrate-
induced expression of PXMP1-L with other peroxisomal ABC
transporters was observed so that an obligate exclusive hetero-
dimer formation is not likely to occur. The data presented will be
particularly useful for the generation of a mouse model defective
in PXMP1-L in order to elucidate the yet unknown function of
this protein.
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1. Introduction
We and others have recently cloned the cDNA of the hu-
man peroxisomal membrane protein 1-like protein (syno-
nyms: peroxisomal membrane protein 69, PMP69; PMP70-
related protein, P70R), a novel human membrane protein
which belongs to the superfamily of integral membrane trans-
porter proteins containing an ATP binding cassette (ABC
transporter) [1,2]. PXMP1-L is localized exclusively within
the peroxisomal membrane. Members of the ABC-transporter
superfamily are involved in the transport of a variety of sub-
strates across biological membranes [3]. Three other members
of the family have been located within the peroxisomal mem-
brane: the adrenoleukodystrophy protein (ALDP) [4], the per-
oxisomal membrane protein 1 (PXMP1, PMP70) [5] and the
adrenoleukodystrophy-related protein (ALDRP) [6,7]. Defects
in the ALD gene are obligate in X-linked adrenoleukodystro-
phy (ALD; McKusick 300100), a demyelinating disorder of
the nervous system with marked heterogeneity of clinical man-
ifestations even between a¡ected individuals carrying the same
mutation [8,9]. ALDP is likely to be involved in the peroxi-
somal import of very long chain fatty acids (VLCFA; sC22)
into the peroxisome since VLCFA accumulate in tissues of
ALD patients. This hypothesis is supported by yeast studies
[10]. The functions of ALDRP, PXMP1 (PMP70) and
PXMP1-L are not known. All four peroxisomal ABC trans-
porters conform to the model of an ABC half-transporter so
that dimerization is necessary to constitute a functional trans-
porter. It is currently not known in which way peroxisomal
ABC transporters dimerize. Heterodimer formation as well as
homodimer formation or both is conceivable. Induction of
peroxisomal ABC transporters (ALDP, ALDRP, PXMP1)
by feno¢brate, a potent peroxisome proliferator activating
PPARK [14], has previously been studied in the rat. Upon
treatment with feno¢brate expression of the ALD gene was
not altered whereas that of PXMP1 and ALDR genes was
strongly increased in intestine and liver, respectively [15].
The data available on the tissue expression pattern of individ-
ual peroxisomal ABC transporters [6,7,16] or their induction
by feno¢brate [15] did not reveal a clue to distinct pairs
among these half-transporters. Expression analysis of the
fourth transporter (PXMP1-L) was not possible at this time.
The knowledge of primary structure similarities to ALDP, a
putative lipid transporter, and to peroxisomal lipid transport-
ers (Pxa1p, Pxa2p) in Saccharomyces cerevisiae have led to the
hypothesis that the other half-transporters ALDRP, PXMP1,
and PXMP1-L might also be involved in lipid translocation
across the peroxisomal membrane [1,2]. Several groups have
independently established a mouse model for ALD by tar-
geted disruption of the ALD gene [11^13]. These models do
not show neurologic abnormalities but are clearly a¡ected by
a defect of VLCFA L-oxidation. This phenotype might be
in£uenced by the overlap or redundancy of function between
ALDP and the other related peroxisomal ABC half-transport-
ers. One strategy to prove such hypotheses is the generation of
mouse models de¢cient for more than one peroxisomal ABC
transporter. As a prerequisite for this strategy we report here
the cloning of the mouse PXMP1-L cDNA encoding the
fourth known peroxisomal ABC half-transporter. We have
analyzed the complete exon-intron structure, the expression
of PXMP1-L mRNA in various tissues of mouse, rat and
human and the putative promoter sequence. We also report
the comparison of constitutive and ¢brate-inducible levels of
expression of peroxisomal ABC transporters in rodents and
man.
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2. Materials and methods
2.1. cDNA cloning
The dbEST expressed sequence database was probed with the hu-
man PXMP1-L amino acid sequence using the tblastn program at the
National Center for Biotechnology Information (NCBI, http://
www.ncbi.nlm.nih.gov). A C57BL/6 mouse clone from the Wash-
U-HHMI Mouse EST Project (GenBank accession number
AA105879), the ORF of which demonstrated signi¢cant similarity
to the human sequence, was obtained from the Resource Center of
the German Human Genome Project (Berlin) [17]. Since the 3P un-
translated end of this clone contained a B1 repetitive element that
might have been a cloning artifact, a 473 bp cDNA probe was am-
pli¢ed from the above EST clone avoiding this repetitive sequence
using primers 1f (5P-GCCATTCTTCACTGATGGGACA-3P) and 1r
(5P-GAGCTCCGCTGCTCAGATG-3P). A 9 day mouse embryonic
cDNA library was screened with this probe labeled by [K-32P]dATP
random priming (Screening Service of the Resource Center of the
German Human Genome Project). A positive clone containing a
PXMP1-L cDNA fragment (MPMGc559E0541Q3) was isolated and
sequenced. The 5P end of the cDNA was completed by RACE-PCR
using mouse liver adapter-ligated cDNA (Marathon-Ready mouse
liver cDNA, Clontech).
For feno¢brate induction studies in rats, a rat PXMP1-L cDNA
fragment was ampli¢ed from random-primed rat cardiomyocyte
cDNA with primers 1fh (5P-CTTCAGACCCAGAGGGAGCTG-3P)
and 2rh (5P-CCCGTGTTGCCTGTGATGAGC-3P) derived from the
human cDNA sequence. The resulting 474 bp product was cloned and
sequenced to con¢rm orthologous sequence. Feno¢brate treatment of
rats was performed as described previously [15].
2.2. Northern blots
A BALB/c mouse multiple tissue Northern blot containing 2 Wg
poly(A) mRNA per lane was purchased from Clontech. The 473
bp cDNA mentioned above was [K-32P]dATP labeled by random
priming and puri¢ed from unincorporated nucleotides by size exclu-
sion chromatography using Sephadex G50 or ProbeQuant G-50 Mi-
cro Columns (Pharmacia). Signals obtained in Northern analysis were
compared to those detected by human actin or rat glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) control probes. Ethidium bro-
mide staining of gels prior to blotting was also used as loading con-
trol. RNA extraction and Northern blot analysis of rat tissues were
performed as described previously [15].
2.3. Genomic structure analysis
A 129/Ola mouse genomic DNA cosmid library was screened with
the 473 bp cDNA probe described above. Three positive clones were
isolated. Cosmid DNA was prepared using ion exchange column pu-
ri¢cation (Midiprep Kit, Qiagen). Multiple exon-exon PCR reactions
were performed using cosmid DNA as template to amplify complete
introns and to obtain intron sizes. In order to get the precise intron-
exon boundaries including exon-£anking intronic sequences the result-
ing PCR products were sequenced from either end using the ampli¢-
cation primers.
2.4. Sequencing of the putative promoter region
The putative promoter region was directly sequenced by £uorescent
dideoxy dye terminator technology using cosmid DNA preparations
as templates. Sequencing of long templates involved the use of BigDye
terminator sequencing technology (ABI). All DNA sequencing was
performed on an ABI 377 automated sequencer.
3. Results
3.1. Mouse PXMP1-L cDNA and primary protein structure
We have cloned a 2308 bp cDNA of the mouse ortholog of
the human PXMP1-L gene. The 1818 bp open reading frame
encodes a protein of 606 amino acids with a predicted molec-
ular weight of 69 kDa. The deduced amino acid sequence
shows 89.4% identity to human PXMP1-L (Fig. 1). The 3P
untranslated region of the cDNA contains a B1 repetitive
element ranging from bp 2173 to 2309.
3.2. PXMP1-L transcription in various tissues of mouse
and rat
Northern blot analysis demonstrates the presence of
PXMP1-L speci¢c mRNA in all tissues examined in mouse
(Fig. 2) and rat (Fig. 3). A single transcript of approximately
2.4 kb was observed in both species. In mouse, PXMP1-L is
predominantly expressed in liver whereas the rat expression
pattern shows a more even distribution similar to the pattern
previously reported for the human [1].
3.3. E¡ects of feno¢brate diet on the transcription of
PXMP1-L in rats
In contrast to other peroxisomal ABC transporters such as
PXMP1 (PMP70) and ALDR, PXMP1-L transcription was
not induced by feno¢brate in rats (Fig. 3). A similar result
(i.e. no change in transcription by feno¢brate) has previously
been described for the adrenoleukodystrophy gene [15].
3.4. Characterization of the region upstream of the
transcriptional start
1.1 kb of genomic sequence immediately upstream of the
transcriptional start have been obtained. A TATA box was
not observed which is consistent with a housekeeping function
of PXMP1-L. Potential Sp1 binding sites have been found at
positions 332 to 320, 3121 to 3117 and 3347 to 3342. The
putative promoter region did not reveal apparent peroxisome
proliferator responsive elements (PPRE) [18^20]. Such an el-
ement, however, may theoretically be positioned further up-
stream [20].
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Fig. 2. Northern analysis in various mouse tissues and comparison
to the human. h: heart, b: brain, sp: spleen, lu: lung, li : liver, sk:
skeletal muscle, k: kidney, t : testis, pl: placenta, pa: pancreas. In
the mouse PXMP1-L mRNA is predominantly expressed in liver.
Hybridization with a human actin probe was performed as loading
control.
Fig. 3. Northern analysis for the presence of PXMP1-L mRNA in
various tissues from feno¢brate-treated and untreated rats. Pretrans-
fer ethidium bromide staining of poly(A) RNA and hybridization
with a glyceraldehyde-3-phosphate dehydrogenase cDNA probe
were used as loading controls. c: untreated, f: feno¢brate-treated
rats; sk: skeletal muscle, h: heart, b: brain, lu: lung, li : liver,
ki : kidney, in: small intestine, sp: spleen.
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3.5. Determination of the complete exon-intron structure
The genomic organization was determined by PCR ampli-
¢cation of genomic fragments with cDNA-derived primers
using a cosmid clone containing the entire murine PXMP1-
L gene. Overlapping fragments spanning the complete coding
region were generated and sequenced. Comparison of the ob-
tained genomic sequence with the cDNA sequence revealed
that the PXMP1-L gene consists of 19 exons and 18 introns
(Fig. 4). The last exon is the largest one containing 506 bp.
The other exons range in length between 37 bp and 209 bp.
All exon-intron boundaries conform to the GT-AG rule. We
have fully sequenced nine introns (introns 2, 5, 8^10, 12, 14,
15 and 18) and determined the exon-£anking intronic sequen-
ces of all other introns. The approximate sizes of introns not
fully sequenced were determined by agarose gel electrophore-
sis of corresponding PCR products. The total size of the mur-
ine PXMP1-L gene is approximately 21 kb (Fig. 4).
4. Discussion
We and others have previously reported the cloning of
PXMP1-L a novel human membrane protein belonging to
the group of peroxisomal ABC half-transporters [1,2]. Its clos-
est homolog is the peroxisomal membrane protein 1 (PXMP-
1) also known as PMP70. In addition to ALDP, ALDRP and
PXMP1, it constitutes the fourth peroxisomal ABC transport-
er known to date. The function of PXMP1-L is still unknown,
but the similarity to other peroxisomal ABC transporters sug-
gests a role in lipid translocation across the peroxisomal mem-
brane. The complete loss of peroxisomal functions in perox-
isome biogenesis defects (PBD) in humans is not lethal
prenatally. This has also been shown in mouse models of
PBD [21,22]. Therefore it is to be expected that disruption
of any peroxisomal gene will yield a phenotype viable until
birth and accessible to further characterization. The example
of ALD mouse models [11^13] has demonstrated that the
function of a peroxisomal ABC transporter can be studied
by gene disruption. As a prerequisite to studying PXMP1-L
in an animal model we have cloned the orthologous gene of
the mouse. The length of the cloned cDNA corresponds to the
transcript size of 2.4 kb observed in Northern blot analysis so
that it is probably full length. This transcript size is identical
in all tissues and also identical to rat and human so that the
formation of alternative transcripts (as have been observed for
ALDRP) appears not to play a role in PXMP1-L function.
The homology of 89.4% identical amino acids as compared
with human PXMP1-L (Fig. 1) proves that it is in fact the
murine ortholog. A B1 repetitive element [23] is part of the
transcript in the 3P untranslated region. The role of such a
mobile element becoming part of the transcript is not known.
The insertion of this element into the transcript might have
led to an alteration in stability and thus expression level of
this gene during evolution. The composition of the coding
region of the PXMP1-L gene from 19 exons is very similar
to that of the human ortholog in that all exon-intron boun-
daries are conserved whereas intron sizes are variable [24]. No
apparent similarities to the genomic structure of the human
ALD gene [25], the human ALDR gene (Holzinger et al.,
unpublished data) or the human PXMP1 gene [26] were
found, so that the genomic organization data do not provide
a clue to an interaction of PXMP1-L with other peroxisomal
ABC transporters.
Interestingly the tissue distribution of constitutive mRNA
expression in BALB/c mice appears to be di¡erent from the
rat and the human in that the liver is the predominant site of
expression in the mouse. This ¢nding might well be related to
species di¡erences in peroxisomal lipid metabolism not proven
to date. Some of the most important functions of peroxisomes
include the synthesis of plasmalogens, bile acids, cholesterol
and dolichol, and the oxidation of fatty acids sC22,
branched chain fatty acids, dicarboxylic acids, unsaturated
fatty acids and prostaglandins [27]. Although standard labo-
ratory diet was given to these mice changes in response to the
diet might also be of importance. Dietary polyunsaturated
fatty acids, for example, have been shown to modulate the
transcription of several hepatic lipogenic genes [28]. The in-
vestigation of the e¡ect of lipid enriched or depleted dietary
regimens might yield a clue to the function of PXMP1-L. In
contrast to BALB/c mice analyzed in this study, Albet et al.
(unpublished data) have observed expression of PXMP1-L in
the Ico:OF1 mouse kidney at higher levels than in the liver so
that there are apparent inter-strain di¡erences. Interspecies
di¡erences in tissue expression have been observed for other
ABC transporters: in human, ALDP is expressed stronger in
skeletal muscle than in lung and heart [4] but the reverse
observation was made in mouse (Albet et al., unpublished
data) and rat [15]; PMP70 is strongly expressed in the liver
of rat, mouse and human. In the mouse expression levels of
kidney and heart are almost as high as those of liver (Albet et
al., unpublished data). The comparison of peroxisomal lipid
metabolism between strains and species in relation to expres-
sion levels of peroxisomal ABC transporters will be an inter-
esting ¢eld of further investigations and may contribute to
assessing the precise function of these transporters. It appears
to be of importance that di¡erences between mouse and hu-
man expression patterns are kept in mind when mouse models
are generated by targeted gene disruption.
Three of the four peroxisomal ABC transporters have pre-
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Fig. 4. Genomic organization of the mouse PXMP1-L gene. Exon sizes (in bp) are indicated above, intron sizes below the horizontal line.
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viously been examined for induction of mRNA transcription
in rats treated with feno¢brate, a potent peroxisome prolifer-
ator [14,15]. PXMP1 (PMP70) transcripts were found to be
induced in liver and intestine, ALDR was induced in liver
only and ALD was not found to be induced in any tissues
[15]. The cloning of the PXMP1-L cDNA enabled us to com-
pare all four peroxisomal ABC transporters with respect to
feno¢brate induction in the rat. As was the case with ALD
[15], we did not see any change in the level of PXMP1-L
mRNA after feno¢brate treatment of rats. This would be in
accordance with the absence of PPREs in the putative pro-
moter region of the mouse gene although species di¡erences in
the action of peroxisome proliferators have been observed
[29^31]. From these data and the analysis of tissue expression
it can be concluded that there is no apparent pair of perox-
isomal ABC half-transporters showing coordinate expression
so that an obligate exclusive dimerization between any two of
the four peroxisomal ABC transporters appears to be un-
likely. In accordance, Tro¡er-Charlier and colleagues [32]
have found strikingly di¡erent expression of ALDP and
ALDRP in mouse tissues and various human cell lines.
In S. cerevisiae two ABC half-transporters (Pxa1p and
Pxa2p) were found to form heterodimers [33]. Pxa2p was
demonstrated to be responsible for C18:1-CoA, but not
C8:0-CoA import into the peroxisome [10]. This could be
interpreted as an indication of the co-existence of homo-
and heterodimers of peroxisomal ABC transporters in this
organism.
In this study, the comparison of expression data of
PXMP1-L in rodents with the other peroxisomal ABC trans-
porters did not reveal any evidence of coordinate expression
or induction of any pair of these proteins. These ¢ndings are
consistent with the hypothesis that peroxisomal ABC trans-
porters form homodimers. Due to the high conservation and
identical subcellular localization it has previously been pro-
posed that ALDRP, PXMP1 and PXMP1-L might play a role
as modi¢ers of the clinical course of adrenoleukodystrophy.
This hypothesis would imply a similar, possibly overlapping
function of these membrane proteins. In fact it has recently
been demonstrated that the L-oxidation defect present in cell
lines derived from ALD patients can be corrected not only by
transfection of ALD cDNA but also by overexpression of
PXMP1 [34].
The genomic organization of the murine PXMP1-L gene
presented here is a prerequisite for the generation of mouse
models lacking either PXMP1-L alone or in combination with
the other peroxisomal ABC transporters.
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